Eli Lilly & Co. stock underperforms Thursday when compared to competitors
Shares of Eli Lilly & Co. LLY shed 1.72% to $782.35 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.54% to 6,051.25 and Dow Jones Industrial Average DJIA falling 0.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 504.34% and currently trading at $799.00. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,
The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...
With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
A national medical firm has announced it will launch a $3 billion expansion of its Kenosha County facility and will bring 750 ...
Tirzepatide had received approval in a single-dose prefilled pen format in January 2024 for use as an adjunct to diet and ...
Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
Eli Lilly announces $15 billion share buyback plan and 15% dividend boost amidst mixed technical signals. Investors are ...
Eli Lilly is doubling down on manufacturing investments announcing a US3 billion expansion of its Wisconsin facility ...
The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback